Outcomes of @entity292 following catheter ablation of XXXX treated with surgical repair versus esophageal stenting.

@entity1 @entity326 @entity999 @entity292 @entity1576 @entity955
INTRODUCTION: Atrioesophageal @entity292 (AEF) is a rare but devastating complication of radiofrequency catheter ablation (RFCA) of @entity955 ( @entity955 ). Surgical repair and esophageal stents are available treatment options for AEF. We report outcomes of these 2 management strategies. METHODS: Nine @entity1 with AEF post-RFCA for @entity955 were included in this study. AEF was diagnosed based on symptoms and chest CT imaging. Of the 9 @entity1 , 5 received stents and 4 underwent surgical repair of @entity292 . RESULTS: @entity955 ablation was performed under general anesthesia (n = 4) or conscious sedation (n = 5). During ablation, RF power was maintained between 25 and 35 Watts in areas close to the esophagus and energy delivery discontinued when esophageal temperature reached 38   C. Seven @entity1 underwent ablation with 3.5-mm open-irrigated catheter, 1 with 8-mm nonirrigated catheter, and 1 had surgical epicardial ablation. Seven @entity1 received proton pump inhibitor and sucralfate before and after procedure. AEF symptoms developed within 2   6 weeks from ablation. Esophageal stenting was performed in 5 @entity1 (median age 58 years, median time from RFCA 4 weeks) and 4 underwent surgical repair (median age 54 years, median time from RFCA 4 weeks) within 2   4 hours from diagnosis. All 5 @entity1 receiving stents died within 1 week of the procedure due to @entity999 , @entity326 , or @entity1576 . On the other hand, the 4 @entity1 that received surgical repair were alive at median follow-up of 2.1 years (P = 0.005). CONCLUSIONS: Esophageal stenting should be discouraged and prompt surgical repair is crucial for survival in @entity1 with @entity292 .
